Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Targeted Ibuprofen Treatment of PDA in Very Premature Infants
NCT01630278Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Mar 2012
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by CHU de Nantes. Started Mar 2012; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT01630278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630278.